呼吸器外科(2)

研究成果

年別の研究成果 2000 2017 2018 2019 2023

• 242 学術誌
• 19 総説
• 3 コメント/討論
• 2 レター

年別の研究成果

年別の研究成果

検索結果

• 2021

  The mechanisms of resistance to second- and third-generation ALK inhibitors and strategies to overcome such resistance

  Haratake, N., Toyokawa, G., Seto, T., Tagawa, T., Okamoto, T., Yamazaki, K., Takeo, S. & Mori, M., 2021, In: Expert Review of Anticancer Therapy. 21, 9, p. 975-988 14 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Anaplastic Lymphoma Kinase Inhibitor 100%
  • Anaplastic Lymphoma Kinase 66%
  • Non Small Cell Lung Cancer 33%
  • Clinical Trial 33%
  • Crizotinib 33%
  6 被引用数 (Scopus)
• 2019

  The prognostic impact of obstructive lung disease on survival of never smokers with resected non-small-cell lung cancer: A comparison with smokers

  Akamine, T., Tagawa, T., Shimokawa, M., Matsubara, T., Kozuma, Y., Haratake, N., Takamori, S., Toyokawa, G. & Maehara, Y., 5月 1 2019, In: Interactive cardiovascular and thoracic surgery. 28, 5, p. 735-743 9 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  Open Access

  • Smoking 100%
  • Patient 50%
  • Non Small Cell Lung Cancer 43%
  • Obstructive Lung Disease 43%
  • Recurrence Free Survival 18%
  5 被引用数 (Scopus)
• 2018

  Atezolizumab in non-squamous non-small cell lung cancer

  Akamine, T., Toyokawa, G., Tagawa, T. & Seto, T., 9月 1 2018, In: Journal of Thoracic Disease. 10, p. S3155-S3159

  研究成果: ジャーナルへの寄稿 › 総説 › 査読
  5 被引用数 (Scopus)

• Combination Therapy of Radiotherapy and Anti-PD-1/PD-L1 Treatment in Non–Small-cell Lung Cancer: A Mini-review

  Takamori, S., Toyokawa, G., Takada, K., Shoji, F., Okamoto, T. & Maehara, Y., 1月 2018, In: Clinical Lung Cancer. 19, 1, p. 12-16 5 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Programmed Cell Death 100%
  • Ligand 44%
  • Lung Cancer 44%
  • Programmed Death 1 Ligand 1 33%
  • Combination Therapy 11%
  57 被引用数 (Scopus)

• Spotlight on lorlatinib and its potential in the treatment of NSCLC: The evidence to date

  Akamine, T., Toyokawa, G., Tagawa, T. & Seto, T., 2018, In: OncoTargets and Therapy. 11, p. 5093-5101 9 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  Open Access

  • Anaplastic Lymphoma Kinase 100%
  • Non Small Cell Lung Cancer 35%
  • Protein Tyrosine Kinase Inhibitor 35%
  • Anaplastic Lymphoma Kinase Inhibitor 14%
  • Metastasis 7%
  39 被引用数 (Scopus)

• The Significance of the PD-L1 Expression in Non–Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers

  Takada, K., Toyokawa, G., Shoji, F., Okamoto, T. & Maehara, Y., 3月 2018, In: Clinical Lung Cancer. 19, 2, p. 120-129 10 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Lung Cancer 100%
  • Programmed Cell Death 88%
  • Cells 77%
  • Apoptosis 77%
  • Ligand 66%
  54 被引用数 (Scopus)
• 2015

  Multimodality treatment with surgery for locally advanced non-small-cell lung cancer with n2 disease: A review article

  Toyokawa, G., Takenoyama, M. & Ichinose, Y., 1月 1 2015, In: Clinical Lung Cancer. 16, 1, p. 6-14 9 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Retrospective Study 100%
  • Prospective Study 100%
  • Therapeutic Procedure 83%
  • Treatment 83%
  • Surgery 66%
  15 被引用数 (Scopus)

• Updated evidence on the mechanisms of resistance to ALK inhibitors and strategies to overcome such resistance: Clinical and preclinical data

  Toyokawa, G. & Seto, T., 6月 9 2015, In: Oncology Research and Treatment. 38, 6, p. 291-298 8 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Anaplastic Lymphoma Kinase 100%
  • ALK Inhibitor 58%
  • Anaplastic Lymphoma Kinase Inhibitor 58%
  • Therapeutic Procedure 25%
  • Non Small Cell Lung Cancer 25%
  77 被引用数 (Scopus)
• 2014

  ALK inhibitors: What is the best way to treat patients with ALK⁺ non-small-cell lung cancer?

  Toyokawa, G. & Seto, T., 9月 1 2014, In: Clinical Lung Cancer. 15, 5, p. 313-319 7 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Anaplastic Lymphoma Kinase 100%
  • Crizotinib 100%
  • Anaplastic Lymphoma Kinase Inhibitor 70%
  • Non Small Cell Lung Cancer 50%
  • Lung Cancer 30%
  29 被引用数 (Scopus)

• Anaplastic lymphoma kinase rearrangement in lung Cancer: Its biological and clinical significance

  Toyokawa, G. & Seto, T., 11月 1 2014, In: Respiratory Investigation. 52, 6, p. 330-338 9 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Anaplastic Lymphoma Kinase 100%
  • Non Small Cell Lung Cancer 50%
  • Crizotinib 40%
  • Lung Cancer 30%
  • Chemotherapy 20%
  13 被引用数 (Scopus)
• 2011

  Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': Epidemiology and clinical features

  Yano, T., Haro, A., Shikada, Y., Maruyama, R. & Maehara, Y., 8月 2011, In: International Journal of Clinical Oncology. 16, 4, p. 287-293 7 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Smoking 100%
  • Non Small Cell Lung Cancer 43%
  • Lung Cancer 37%
  • Patient 25%
  • Clinical Trial 18%
  85 被引用数 (Scopus)
• 2009

  Current status of pulmonary metastasectomy from primary epithelial tumors

  Yano, T., Shoji, F. & Maehara, Y., 2月 2009, In: Surgery today. 39, 2, p. 91-97 7 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Metastasectomy 100%
  • Video-Assisted Thoracoscopic Surgery 75%
  • Primary Tumor 50%
  • Surgery 50%
  • Patient 25%
  39 被引用数 (Scopus)
• 2008

  Treatment of malignant pleural mesothelioma--present status and future view

  Yano, T., Morodomi, Y., Ito, K., Miura, N., Takenaka, T., Kawano, D., Shoji, F. & Maehara, Y., 4月 2008, In: Fukuoka igaku zasshi = Hukuoka acta medica. 99, 4, p. 74-79 6 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読
  1 被引用数 (Scopus)
• 2007

  Recent topics in surgical treatment of lung cancer

  Yoshino, I., Shoji, F., Yoneya, T. & Maebara, Y., 8月 1 2007, In: Gan to kagaku ryoho. Cancer & chemotherapy. 34, 8, p. 1207-1210 4 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読
• 2004

  Clinical patterns and treatment outcome of elderly patients in clinical stage IB/II non-small cell lung cancer

  Okamoto, T., Maruyama, R., Shoji, F., Ikeda, J., Miyamoto, T., Nakamura, T., Asoh, H. & Ichinose, Y., 9月 1 2004, In: Journal of Surgical Oncology. 87, 3, p. 134-138 5 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Patient 100%
  • Surgery 83%
  • Radiation Therapy 83%
  • Adenocarcinoma 66%
  • Elderly Patient 66%
  4 被引用数 (Scopus)

• Elective video-assisted thoracoscopic lung biopsy for interstitial lung disease

  Yamaguchi, M., Yoshino, I., Suemitsu, R., Osoegawa, A., Kameyama, T., Tagawa, T., Fukuyama, S. & Maehara, Y., 3月 2004, In: Asian Cardiovascular and Thoracic Annals. 12, 1, p. 65-68 4 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Interstitial Lung Disease 100%
  • Patient 75%
  • Therapeutic Procedure 75%
  • Lung Biopsy 50%
  • Diagnosis 25%
  16 被引用数 (Scopus)
• 2003

  Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice

  Shoji, F., Yonemitsu, Y., Okano, S., Yoshino, I., Nakagawa, K., Nakashima, Y., Hasegawa, M., Sugimachi, K. & Sueishi, K., 2月 2003, In: Gene Therapy. 10, 3, p. 213-218 6 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Interleukin 10 100%
  • Sendai Virus 88%
  • Gene Transfer 77%
  • Cyclosporine 55%
  • Epithelium 55%
  10 被引用数 (Scopus)

• Current aspects of lung transplantation in eastern countries and Japan

  Yoshino, I., Yamaguchi, M., Fukuyama, S., Tagawa, T., Kameyama, T., Osoegawa, A. & Maehara, Y., 3月 2003, In: Fukuoka igaku zasshi = Hukuoka acta medica. 94, 3, p. 37-42 6 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読

  • Lung Transplantation 100%
  • Patient 50%
  • Donor 50%
  • Therapeutic Procedure 25%
  • Transplantation 25%
• 2002

  Departmental review of surgical cases in the last 17 years: Lung neoplasm

  Yoshino, I., Fukuyama, S., Kameyama, T., Shikada, Y., Yoneya, T., Baba, H., Tomiyasu, M., Suemitsu, R., Shoji, F., Tachiishi, M., Yano, A., Sugio, K., Mitsutomi, T., Ishida, T. & Yasumoto, K., 3月 2002, In: Fukuoka igaku zasshi = Hukuoka acta medica. 93, 3 Suppl, p. 34-37 4 p.

  研究成果: ジャーナルへの寄稿 › 総説 › 査読